United States · Platforms & data · Stocktwits

RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study

Published by Stocktwits · United States 10 h ago

The drug met its primary trial goal, producing a statistically significant 3.1-point improvement over placebo on a standard clinician-rated scale that measures the severity of…

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading

The Motley Fool

Stock Market Today, Oct. 20: IREN Slides on Funding Worries and Rate Fears

MarketBeat

Alaska Air Group (NYSE:ALK) Announces Quarterly Earnings Results

MarketWatch

It’s no secret what the best financial advice for retirement is — but most people ignore it anyway

Investing.com

Live Energy Minerals enters option deal for New Brunswick property

Yahoo Finance

Stock Market Today, Oct. 20: AGNC Investment Rises on Stronger Sector Tone Despite Book-Value Decline

Benzinga